Cargando…

Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia

In most cases, laryngomalacia presents as a mild disease, and the symptoms resolve after wait-and-see policy. Up to 20 % of patients present with severe laryngomalacia and may require surgery (i.e. supraglottoplasty); however, the indication for surgery is not firmly established yet. The goal of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Heijden, Martijn, Dikkers, Frederik G., Halmos, Gyorgy B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858546/
https://www.ncbi.nlm.nih.gov/pubmed/26924742
http://dx.doi.org/10.1007/s00405-016-3943-3
_version_ 1782430819876339712
author van der Heijden, Martijn
Dikkers, Frederik G.
Halmos, Gyorgy B.
author_facet van der Heijden, Martijn
Dikkers, Frederik G.
Halmos, Gyorgy B.
author_sort van der Heijden, Martijn
collection PubMed
description In most cases, laryngomalacia presents as a mild disease, and the symptoms resolve after wait-and-see policy. Up to 20 % of patients present with severe laryngomalacia and may require surgery (i.e. supraglottoplasty); however, the indication for surgery is not firmly established yet. The goal of this study is to determine whether supraglottoplasty results in a better outcome than wait-and-see and to investigate how different comorbidities influence outcome. A retrospective study of pediatric cases of in a tertiary referral center was performed. Photo and video documentation was available and revised in all cases. Electronic and paper charts were reviewed for the following variables: gender, sex, gestational age, birth weight, symptoms, comorbidity, date of endoscopy, severity and type of laryngomalacia, treatment modality and technique and follow-up data and a total 89 patients were included. Supraglottoplasty was found to lead to significantly faster complete improvement of laryngomalacia than wait-and-see policy (5 weeks vs. 29, p = 0.026). Synchronous airway lesions (SALs) were present in 40.4 % of patients and were associated with prolonged symptoms of laryngomalacia (38.5 weeks vs. 14.5, p = 0.043). Supraglottoplasty is safe and effective in treatment of severe laryngomalacia. SALs and comorbidities are frequently found in patients with laryngomalacia and are responsible for longer onset of complaints. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00405-016-3943-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4858546
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-48585462016-05-21 Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia van der Heijden, Martijn Dikkers, Frederik G. Halmos, Gyorgy B. Eur Arch Otorhinolaryngol Laryngology In most cases, laryngomalacia presents as a mild disease, and the symptoms resolve after wait-and-see policy. Up to 20 % of patients present with severe laryngomalacia and may require surgery (i.e. supraglottoplasty); however, the indication for surgery is not firmly established yet. The goal of this study is to determine whether supraglottoplasty results in a better outcome than wait-and-see and to investigate how different comorbidities influence outcome. A retrospective study of pediatric cases of in a tertiary referral center was performed. Photo and video documentation was available and revised in all cases. Electronic and paper charts were reviewed for the following variables: gender, sex, gestational age, birth weight, symptoms, comorbidity, date of endoscopy, severity and type of laryngomalacia, treatment modality and technique and follow-up data and a total 89 patients were included. Supraglottoplasty was found to lead to significantly faster complete improvement of laryngomalacia than wait-and-see policy (5 weeks vs. 29, p = 0.026). Synchronous airway lesions (SALs) were present in 40.4 % of patients and were associated with prolonged symptoms of laryngomalacia (38.5 weeks vs. 14.5, p = 0.043). Supraglottoplasty is safe and effective in treatment of severe laryngomalacia. SALs and comorbidities are frequently found in patients with laryngomalacia and are responsible for longer onset of complaints. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00405-016-3943-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-02-29 2016 /pmc/articles/PMC4858546/ /pubmed/26924742 http://dx.doi.org/10.1007/s00405-016-3943-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Laryngology
van der Heijden, Martijn
Dikkers, Frederik G.
Halmos, Gyorgy B.
Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
title Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
title_full Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
title_fullStr Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
title_full_unstemmed Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
title_short Treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
title_sort treatment outcome of supraglottoplasty vs. wait-and-see policy in patients with laryngomalacia
topic Laryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858546/
https://www.ncbi.nlm.nih.gov/pubmed/26924742
http://dx.doi.org/10.1007/s00405-016-3943-3
work_keys_str_mv AT vanderheijdenmartijn treatmentoutcomeofsupraglottoplastyvswaitandseepolicyinpatientswithlaryngomalacia
AT dikkersfrederikg treatmentoutcomeofsupraglottoplastyvswaitandseepolicyinpatientswithlaryngomalacia
AT halmosgyorgyb treatmentoutcomeofsupraglottoplastyvswaitandseepolicyinpatientswithlaryngomalacia